FORTRESS BIOTECH, INC. purchased 68.1% of their position (418.41K shares) of AVENUE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $301.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/12/2023ACC: 0001437749-23-025640
10% Owner
Since Dec 2022
+418.41K
Net shares
Net buyer
$301.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
418.41K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+418.41K
Price / share
$0.72
Trade value
$301.26K
% of position
68.1%
9/8/2023
613.98K→1.03M
Total
Net shares
+418.41K
Net value
$301.26K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/8/2023 | P · Purchase | +418.41K | $0.72 | $301.26K | 68.1% | 613.98K | 1.03M |
| Total | +418.41K | $301.26K | ||||||
Derivative Transactions0
No derivative transactions reported